Upgrade to SI Premium - Free Trial

PTC Therapeutics (PTCT) Misses Q2 EPS by 17c, Revenues Beat

August 6, 2019 5:25 PM
PTC Therapeutics (NASDAQ: PTCT) reported Q2 EPS of ($0.75), $0.17 worse than the analyst estimate of ($0.58). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Management Comments

Next Articles